IDEV - ETF AI Analysis
Top Page
iShares Core MSCI International Developed Markets ETF (IDEV)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.
Broad International Diversification
Holdings spread across many developed countries like Japan, the UK, Europe, and others help reduce the impact of problems in any single market.
Very Low Expense Ratio
The fund’s low ongoing fee means more of the ETF’s returns stay in investors’ pockets instead of going to costs.
Negative Factors
Heavy Tilt to a Few Countries
A large share of assets is concentrated in markets like Japan and a handful of other countries, so setbacks there could noticeably affect the fund.
Sector Concentration in Financials
Significant exposure to financial companies means the ETF may be more sensitive to banking and interest-rate shocks than a more evenly balanced fund.
Some Top Holdings Are Lagging
While several major positions have been strong, at least one large holding has been weak this year, which can drag on overall performance.
IDEV vs. SPDR S&P 500 ETF (SPY)
AUM32.66B
RegionDeveloped Markets
Expense Ratio0.04%
Beta0.76
IssueriShares
Inception DateMar 21, 2017
Dividend Yield3.07%
Asset ClassEquity
Index TrackedMSCI World ex USA IMI
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,450,375
30 Day Avg. Volume1,411,266
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
105.09Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2290
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IDEV Summary
IDEV is an ETF that tracks the MSCI World ex USA IMI index, giving you broad exposure to stocks in developed countries outside the U.S. and Canada. It owns thousands of companies across many sectors and regions, including well-known names like Nestlé and ASML. Investors might consider IDEV to diversify beyond the U.S. market and tap into long-term growth in Europe, Japan, and other developed economies. A key risk is that international stocks can be volatile and are affected by currency swings and global events, so the value of the ETF can go up and down over time.
How much will it cost me?The iShares Core MSCI International Developed Markets ETF (IDEV) has an expense ratio of 0.04%, meaning you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically costs less to operate compared to actively managed funds.
What would affect this ETF?Positive drivers for IDEV could include economic growth in developed markets outside the U.S., particularly in sectors like financials, technology, and healthcare, which are heavily represented in the ETF. However, negative factors such as rising interest rates or geopolitical tensions in Europe and Asia could impact the performance of key holdings like ASML, Nestlé, and HSBC, as well as broader sector trends like energy and industrials. Regulatory changes or currency fluctuations in these regions may also affect returns.
IDEV Top 10 Holdings
IDEV’s story is driven by a global cast of developed-market leaders, with Europe and Asia doing most of the heavy lifting. ASML has been a key engine for the fund, riding strong semiconductor demand, while Mitsubishi UFJ and HSBC add rising financial muscle from Japan and the U.K. On the defensive side, Roche and Novartis are steady health care anchors, helping smooth out bumps. Consumer giant Nestlé and pharma player AstraZeneca have been losing a bit of steam lately, modestly tugging on returns, but no single stock dominates this broadly diversified mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.25% | $727.84M | €572.60B | 143.26% | 76 Outperform | |
| HSBC Holdings | 1.18% | $380.43M | £262.77B | 60.76% | 80 Outperform | |
| Roche Holding AG | 1.08% | $350.37M | $361.51B | 51.16% | 73 Outperform | |
| Royal Bank Of Canada | 0.98% | $318.41M | $293.84B | 57.98% | 75 Outperform | |
| Novartis AG | 0.97% | $312.74M | CHF230.61B | 32.06% | 80 Outperform | |
| Nestlé SA | 0.85% | $276.57M | CHF208.89B | 10.64% | 71 Outperform | |
| Shell (UK) | 0.84% | $271.28M | £181.34B | 24.71% | 73 Outperform | |
| AstraZeneca | 0.82% | $266.34M | $249.26B | 8.64% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 0.80% | $258.37M | ¥39.85T | 52.16% | 76 Outperform | |
| Siemens | 0.79% | $257.20M | €213.28B | 22.18% | 74 Outperform |
IDEV Technical Analysis
Positive
―
Price Trends
89.73
Positive
88.06
Positive
85.26
Positive
Market Momentum
1.18
Negative
67.40
Neutral
93.34
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDEV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 91.08, equal to the 50-day MA of 89.73, and equal to the 200-day MA of 85.26, indicating a bullish trend. The MACD of 1.18 indicates Negative momentum. The RSI at 67.40 is Neutral, neither overbought nor oversold. The STOCH value of 93.34 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IDEV.
IDEV Peer Comparison
Comparison Results
Performance Comparison
IDEV
iShares Core MSCI International Developed Markets ETF
93.56
17.65
23.25%
VEA
Vanguard FTSE Developed Markets ETF
―
―
―
SCHF
Schwab International Equity ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents